ArticlePharmaceuticals (Basel, Switzerland)2022

Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core.

Daniil R Bazanov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.